Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Hecla Mining (HL) PT Raised to $4.75 at Canaccord Genuity
-
TransGlobe Energy Corporation Announces AGM Voting Results, Update on AIM Process and Transition Plans for the Board of Directors
-
Horizonte Minerals Quarterly Financial Statements for the Three Months Ended 31 March 2018
-
Dropbox (DBX) PT Raised to $36 at Canaccord Genuity
-
Triumph Group (TGI) PT Lowered to $26 at Canaccord Genuity
-
HubSpot Inc (HUBS) PT Raised to $135 at Canaccord Genuity
-
The ExOne Company (XONE) PT Lowered to $12 at Canaccord Genuity
-
Obalon Therapeutics (OBLN) PT Lowered to $6 at Canaccord Genuity
-
Acasta Enters into Definitive Agreement to Sell JemPak Corporation
-
Fibrocell Reports First Quarter 2018 Financial Results and Recent Highlights
-
Kush Bottles to Present at Canaccord Genuity's 2nd Annual Cannabis Conference
-
Fibrocell Reports First Quarter 2018 Financial Results and Recent Highlights
-
Global Blockchain Lists Warrants for Trading, Provides Corporate Update and Update on “Fork” Spin-out
-
SailPoint Technologies Holdings (SAIL) PT Raised to $24 at Canaccord Genuity
-
Canaccord Genuity Downgrades Astronics (ATRO) to Hold
-
TransGlobe Energy Corporation Announces First Quarter 2018 Financial and Operating Results
-
Asure Software (ASUR) PT Raised to $21 at Canaccord Genuity
-
Sientra (SIEN) PT Raised to $19 at Canaccord Genuity
-
Lipocine Inc (LPCN) PT Lowered to $1.50 at Canaccord Genuity
-
Pandora (P) PT Raised to $10 at Canaccord Genuity
-
The Chefs' Warehouse, Inc (CHEF) PT Raised to $29 at Canaccord Genuity
-
Natera (NTRA) PT Raised to $18 at Canaccord Genuity
-
Aileron Therapeutics Reports First Quarter 2018 Financial Results
-
Aileron Therapeutics Reports First Quarter 2018 Financial Results
-
Horizonte Announces Vermelho Mineral Resource Confirming Significant Nickel and Cobalt Inventory
-
Canadian Banc Corp. Announces Successful Overnight Offering
-
Mallinckrodt plc (MNK) PT Lowered to $14 at Canaccord Genuity
-
Envision Healthcare (EVHC) PT Raised to $48 at Canaccord Genuity
-
Twilio (TWLO) PT Raised to $52 at Canaccord Genuity
-
Primoris Services Corporation (PRIM) PT Raised to $32 at Canaccord Genuity
-
Penumbra (PEN) PT Raised to $165 at Canaccord Genuity
-
Shopify (SHOP) PT Raised to $160 at Canaccord Genuity
-
Quidel Corp. (QDEL) PT Raised to $65 at Canaccord Genuity
-
Canadian Banc Corp. Announces Overnight Offering
-
Helios and Matheson (HMNY) Provides Financial Update
-
Golden Leaf Holdings to Present at Canaccord Genuity's 2nd Annual Cannabis Conference
-
Canaccord Genuity Upgrades Impinj Inc (PI) to Buy
-
Nevro Corp (NVRO) PT Lowered to $102 at Canaccord Genuity
-
Tactile Systems Technology (TCMD) PT Raised to $46 at Canaccord Genuity
-
Everbridge (EVBG) PT Raised to $46 at Canaccord Genuity
-
Premier, Inc. (PINC) PT Lowered to $37 at Canaccord Genuity
-
Zillow Group (ZG) PT Raised to $60 at Canaccord Genuity
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Reis, Inc. Announces First Quarter 2018 Financial Results
-
Reis, Inc. Announces First Quarter 2018 Financial Results
-
Canaccord Genuity Starts Zuora Inc. (ZUO) at Hold
-
IDEXX Laboratories (IDXX) PT Raised to $225 at Canaccord Genuity

